CN106924195A - A kind of lyophilized technique of injection Paclitaxel liposome composition - Google Patents

A kind of lyophilized technique of injection Paclitaxel liposome composition Download PDF

Info

Publication number
CN106924195A
CN106924195A CN201511031953.5A CN201511031953A CN106924195A CN 106924195 A CN106924195 A CN 106924195A CN 201511031953 A CN201511031953 A CN 201511031953A CN 106924195 A CN106924195 A CN 106924195A
Authority
CN
China
Prior art keywords
hour
hours
incubated
warming
freezes body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201511031953.5A
Other languages
Chinese (zh)
Other versions
CN106924195B (en
Inventor
陈文忠
程光
秦利利
蔡德明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Lvye Pharma Co Ltd
Original Assignee
Nanjing Lvye Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Lvye Pharma Co Ltd filed Critical Nanjing Lvye Pharma Co Ltd
Priority to CN201511031953.5A priority Critical patent/CN106924195B/en
Publication of CN106924195A publication Critical patent/CN106924195A/en
Application granted granted Critical
Publication of CN106924195B publication Critical patent/CN106924195B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides injection Paclitaxel liposome composition obtained in a kind of new freeze drying process, specifically related to a kind of lyophilization cycle is short, low cost, steady quality are homogeneous, product appearance is good and the injection Paclitaxel liposome composition of suitable production, said composition process is simple, and lyophilized rear preparation stabilization, be conducive to industrialized production, reduce production cost, it is to avoid the fluctuating change of liposomal particle size, ensure the performance of drug effect, improve the security of clinical application.

Description

A kind of lyophilized technique of injection Paclitaxel liposome composition
Technical field
The present invention relates to a kind of lyophilized technique method for shortening the injection Paclitaxel liposome composition freeze-drying cycle.
Background technology
Paclitaxel injection in 1992 by U.S. FDA approval listing tumour first-line treatment medicine, but taxol be insoluble in water and Many pharmaceutical medias, therefore, the parenteral solution at home and abroad listing at present be by taxol be dissolved in Cremophor EL with it is anhydrous The preparation being made in the double solvent of ethanol.Cremophor EL in double solvent in vivo can the release of promotion organization amine, Make human body produce the incidence of allergic reaction, milder hypersensitivity reaction to be up to 50%, or even threat to life, and Japanese yew can be aggravated The toxicities such as peripheral nerve toxicity, generation hepatotoxicity, the influence antitumous effect of alcohol, limit traditional paclitaxel injection Clinical practice.
The targeting of liposome, low toxicity, it is efficient the advantages of, increasingly recognize but because liposome existence and stability is poor by people Problem, easily there is aggregation, fusion and Medicated Permeation during storage, and main membrane material is easily aoxidized, hydrolyzed.In order to solve Above-mentioned liposome stability problem not high, presently disclosed lyophilized formulations and preparation method thereof are generally vacuum freeze drying, spraying Drying, supercritical fluid technique etc..
Wherein, liposome is made by freeze drying powder injection using freeze-drying, its holding time in vitro can not only be greatly prolonged, Also it is avoided that medicine produces denaturation simultaneously, is protected oxidizable material in medicine, and microorganism cannot almost be carried out, from And improve the physics and chemical stability of liposome.Such as the patent of invention of Shanghai Ai Lisi Pharmaceutical Technology Co., Ltd A kind of liposome composition of stabilization is disclosed in CN200610028725.7A, by saturated phospholipid and cholesterol as into membrane lipid, Add vitamin E as antioxidant, using sucrose as freeze-dried excipient, prepared using the method for thin film evaporation-freeze-drying, this Planting liposome can be used as the carrier of anti-cancer medicine paclitaxel.The patent of invention of Qingdao Dong Hui medical sci-teches Development Co., Ltd CN201310376983.4 discloses a kind of Docetaxel for Injection nanoparticle and preparation method thereof, is prepared using freeze-drying.
But, above-mentioned freeze drying process there is problems:
Lyophilization cycle is long, influences production capacity, and required input cost is high, additionally, because mostly with actual system in actual production process Product temperature degree is major control temperature, there is larger variable and is difficult to accomplish that front and rear batch products are stable and controllable for quality, causes to criticize and criticizes it Between product quality heterogeneity, and then have an effect on product appearance color and luster, shape and envelop rate etc., percent defective is high in production process.
The present invention is directed to above-mentioned technical problem, there is provided a kind of lyophilization cycle is short, low cost, steady quality are homogeneous, product appearance It is good, improve yield and be adapted to the injection Paclitaxel liposome composition of production, said composition process is simple, and it is lyophilized after system Agent stabilization, is conducive to large-scale industrial production, reduces production cost, it is to avoid the fluctuating change of liposomal particle size, it is ensured that The performance of drug effect, improves the security of clinical application.
The content of the invention
The present invention provides injection Paclitaxel liposome composition obtained in a kind of new pre-freeze method.
The freeze drying process of the preparation injection Paclitaxel liposome that the present invention is provided, comprises the steps of:
During the Japanese yew raw polyol of recipe quantity, lecithin, cholesterol first are dissolved in into isopropanol or alcohol solvent, 50~60 DEG C of constant temperature are removed Solvent, adds the amino acid and mannitol or the aqueous solution of glucose dissolved with recipe quantity, after dissolving, with ultrasonic wave or high-pressure homogenization Pump treatment, quantitative separating enters in the bottle container of 30ml XiLin, places in freeze drier, and solution was dropped rapidly in 0.5~2 hour To -50 DEG C~-80 DEG C, and 4~8 hours are incubated, obtain freezes body, application of vacuum makes vacuum less than 10pa, then by freezes body - 5 DEG C were warming up in 0.1~2 hour, 1~4 hour is incubated, then freezes body was warming up to 30 DEG C, insulation 3~6 in 1~2 hour Hour, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation.
The freeze drying process that the present invention is provided, preferably comprises the steps of:
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 50~60 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus 1.4g containing lysine 5% glucose solution dissolving film, be homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of filter membrane mistake Bacterium is filtered, is sub-packed in 30ml cillin bottles, placed in freeze drier, solution was rapidly decreased to -60 DEG C in 0.5~2 hour ~-70 DEG C, and 6~8 hours are incubated, freezes body is obtained, application of vacuum makes vacuum less than 10pa, then by freezes body 0.1~0.5 - 5 DEG C are warming up in hour, 1~4 hour is incubated, then freezes body was warming up to 25~35 DEG C in 1~2 hour, insulation 4~6 is small When, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation.
More preferably:
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 50~60 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus 1.4g containing lysine 5% glucose solution dissolving film, be homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of filter membrane mistake Bacterium is filtered, is sub-packed in 30ml cillin bottles, placed in freeze drier, solution was rapidly decreased to -65 DEG C in 1 hour, and Insulation 8 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body was warming up in 0.5 hour - 5 DEG C, 2 hours are incubated, then freezes body was warming up to 30 DEG C in 1 hour, be incubated 4 hours, be passed through nitrogen, helium or argon Gas, obtains appearance uniform, off-white color bulk Paclitaxel liposome preparation, content of taxol 100%, envelop rate 99%, volume Average grain diameter 130nm, peroxidase 12 %, moisture 1%, overall lyophilization cycle 16.5 hours.
The present invention is processed by the cooling to liquid, shortens lyophilization cycle, reduces production cost, is improve product quality and is obtained Rate, is conducive to industrialized production.
Specific embodiment
Embodiment 1:
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 50 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus containing lysine 1.4g's 5% glucose solution dissolving film, is homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of membrane filtration It is degerming, it is sub-packed in 30ml cillin bottles, place in freeze drier, solution was rapidly decreased to -65 DEG C in 1 hour, and protect Temperature 8 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body is warming up into -5 DEG C in 0.3 hour, Insulation 4 hours, then freezes body was warming up to 30 DEG C in 1 hour, 4 hours are incubated, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation, obtains the off-white color bulk Paclitaxel liposome preparation of appearance uniform, content of taxol 100%, envelop rate 99%, average grain diameter 130nm, peroxidase 12 %, overall lyophilization cycle 18.3 hours.
Embodiment 2:
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 60 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus containing lysine 1.4g's 5% glucose solution dissolving film, is homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of membrane filtration It is degerming, it is sub-packed in 30ml cillin bottles, place in freeze drier, solution was rapidly decreased to -50 DEG C in 0.5 hour, and protect Temperature 7 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body is warming up into -5 DEG C in 1.5 hours, Insulation 3 hours, then freezes body was warming up to 35 DEG C in 1 hour, 4 hours are incubated, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation, obtains the off-white color bulk Paclitaxel liposome preparation of appearance uniform, content of taxol 98%, envelop rate 99%, average grain diameter 119nm, peroxide 1%, overall lyophilization cycle 17 hours.
Embodiment 3:
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 55 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus containing lysine 1.4g's 5% glucose solution dissolving film, is homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of membrane filtration It is degerming, it is sub-packed in 30ml cillin bottles, place in freeze drier, solution was rapidly decreased to -65 DEG C in 1 hour, and protect Temperature 8 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body is warming up into -5 DEG C in 1 hour, Insulation 2 hours, then freezes body was warming up to 30 DEG C in 1 hour, 4 hours are incubated, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation, obtains the off-white color bulk Paclitaxel liposome preparation of appearance uniform, content of taxol 99%, envelop rate 99%, average grain diameter 125nm, peroxidase 12 %, overall lyophilization cycle 17 hours.
Embodiment 4:
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 50~60 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus 1.4g containing lysine 5% glucose solution dissolving film, be homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of filter membrane mistake Bacterium is filtered, is sub-packed in 30ml cillin bottles, placed in freeze drier, solution was rapidly decreased to -65 DEG C in 2 hours, and Insulation 8 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body was warming up in 0.1 hour - 5 DEG C, 3 hours are incubated, then freezes body was warming up to 25 DEG C in 1 hour, be incubated 4 hours, be passed through nitrogen, helium or argon Gas, obtains Paclitaxel liposome preparation.Content of taxol 100%, envelop rate 100%, average grain diameter 110nm, peroxidase 12 %, Overall lyophilization cycle 18.1 hours.
Embodiment 5
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 55 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus containing lysine 1.4g's 5% mannitol solution dissolving film, is homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of membrane filtration It is degerming, it is sub-packed in 30ml cillin bottles, place in freeze drier, solution was rapidly decreased to -65 DEG C in 2 hours, and protect Temperature 8 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body is warming up into -5 DEG C in 0.3 hour, Insulation 3 hours, then freezes body was warming up to 25 DEG C in 1 hour, 4 hours are incubated, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation, obtains the off-white color bulk Paclitaxel liposome preparation of appearance uniform, content of taxol 98%, envelop rate 98%, average grain diameter 140nm, peroxide 3%, overall lyophilization cycle 18.3 hours.
Embodiment 6
First the taxol 6.0g of recipe quantity, refined lecithin 72g and cholesterol 10.8g are put in round-bottomed flask, plus ethanol in proper amount Make to be completely dissolved into clear solution into said mixture, put 55 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus containing lysine 1.4g's 5% mannitol solution dissolving film, is homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then with 0.2 μm of membrane filtration It is degerming, it is sub-packed in 30ml cillin bottles, place in freeze drier, solution was rapidly decreased to -65 DEG C in 1 hour, and protect Temperature 8 hours, obtains freezes body, and application of vacuum makes vacuum less than 10pa, then freezes body is warming up into -5 DEG C in 0.5 hour, Insulation 2 hours, then freezes body was warming up to 30 DEG C in 1 hour, 4 hours are incubated, nitrogen, helium or argon gas are passed through, obtain Paclitaxel liposome preparation, obtains the off-white color bulk Paclitaxel liposome preparation of appearance uniform, content of taxol 99%, envelop rate 99%, average grain diameter 130nm, peroxidase 12 %, overall lyophilization cycle 16.5 hours.
Comparative example 1:
Note is prepared according to the lyophilized technique method provided in Chinese invention patent CN201310376983 specification specific embodiments Penetrate and use Paclitaxel liposome:
Injection taxol 6.0g, refined lecithin 72g and cholesterol 10.8g is weighed to put in round-bottomed flask, plus ethanol in proper amount is extremely Make to be completely dissolved into clear solution in said mixture, put 50 DEG C of drying under reduced pressure film forming of water bath with thermostatic control, plus containing lysine 1.4g's 5% mannitol solution dissolving film, is homogenized with ultrasonoscope Ultrasonic Pulverization or high-pressure homogenization pump, then is removed with 0.2 μm of membrane filtration Bacterium, is sub-packed in 30ml cillin bottles, places in freeze drier, and the temperature of lyophilized separator for container is reduced into less than -40 DEG C, fast The pallet that speed will be equipped with preparation is put into freeze drying box, is maintained overnight 12 hours, then carries out application of vacuum, makes vacuum in case small In 10pa, then kept for 48 hours by -40 DEG C, -35 DEG C are kept for 24 hours, and -30 DEG C are kept for 12 hours, and -25 DEG C of holdings 12 are small When, -20 DEG C are kept for 6 hours, and -10 DEG C are kept for 6 hours, and -5 DEG C are kept for 6 hours, and 0 DEG C is kept for 6 hours, and 4 DEG C of holdings 4 are small When, nitrogen, helium or argon gas are passed through, obtain off-white color bulk Paclitaxel liposome preparation.Content of taxol 99%, envelop rate 99%, Average grain diameter 130nm, peroxidase 12 %, overall lyophilization cycle 136 hours.
Compared with comparative example 1 by the embodiment of the present application 1-6 as can be seen that the lyophilized technique that the application patent is provided prepares same matter The Paclitaxel liposome of amount standard, lyophilization cycle is greatly shortened, and production capacity is greatly improved, and is effectively reduced production cost.

Claims (3)

1. it is a kind of with desivac prepare injection Paclitaxel liposome composition when freeze drying process, it is characterised in that comprise the steps of: First the Japanese yew raw polyol of recipe quantity, phosphatide, cholesterol are dissolved in ethanol, 50-60 DEG C of constant temperature removes solvent, adds dissolved with prescription The amino acid and mannitol or the aqueous solution of glucose of amount, after dissolving, quantitative separating enters in container, in placement freeze drier, Solution was rapidly decreased to -50 DEG C~-80 DEG C in 0.5~2 hour, and is incubated 4~8 hours, obtain freezes body, application of vacuum makes Vacuum is less than 10pa, then freezes body was warming up into -5 DEG C in 0.1~2 hour, is incubated 1~4 hour, then by freezes body 1~2 30~35 DEG C are warming up in hour, 3~6 hours are incubated, nitrogen, helium or argon gas is passed through, Paclitaxel liposome preparation is obtained.
2. freeze drying process according to claim 1, it is characterized by freeze-drying process is comprised the steps of:By solution in 1~2 hour - 60 DEG C~-70 DEG C are rapidly decreased to, and are incubated 6~8 hours, obtain freezes body, application of vacuum makes vacuum less than 10pa, then will Freezes body was warming up to -5 DEG C in 0.1~0.5 hour, was incubated 1~4 hour, then freezes body was warming up in 1~2 hour 30~35 DEG C DEG C, it is incubated 2~4 hours.
3. freeze drying process according to claim 1, it is characterized by freeze-drying process is:Solution was rapidly decreased to -65 DEG C in 1 hour, And 8 hours are incubated, and freezes body is obtained, application of vacuum makes vacuum less than 10pa, then freezes body was heated up in 0.5 hour To -5 DEG C, 2 hours are incubated, then freezes body was warming up to 30 DEG C in 1 hour, be incubated 4 hours.
CN201511031953.5A 2015-12-31 2015-12-31 Freeze-drying process of paclitaxel liposome composition for injection Active CN106924195B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201511031953.5A CN106924195B (en) 2015-12-31 2015-12-31 Freeze-drying process of paclitaxel liposome composition for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201511031953.5A CN106924195B (en) 2015-12-31 2015-12-31 Freeze-drying process of paclitaxel liposome composition for injection

Publications (2)

Publication Number Publication Date
CN106924195A true CN106924195A (en) 2017-07-07
CN106924195B CN106924195B (en) 2020-11-13

Family

ID=59443710

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201511031953.5A Active CN106924195B (en) 2015-12-31 2015-12-31 Freeze-drying process of paclitaxel liposome composition for injection

Country Status (1)

Country Link
CN (1) CN106924195B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112789472A (en) * 2018-09-27 2021-05-11 玛阿特制药公司 Freeze-drying container

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291474A (en) * 2000-10-19 2001-04-18 南京振中生物工程有限公司 Taxusol-lipid composition and its preparing process
WO2001056548A2 (en) * 2000-02-04 2001-08-09 Lipoxen Technologies Limited Liposomes composition produced by a dehydration-rehydration process
CN102716095A (en) * 2012-06-29 2012-10-10 海南灵康制药有限公司 Paclitaxel vesicle type phospholipid gel injection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056548A2 (en) * 2000-02-04 2001-08-09 Lipoxen Technologies Limited Liposomes composition produced by a dehydration-rehydration process
CN1291474A (en) * 2000-10-19 2001-04-18 南京振中生物工程有限公司 Taxusol-lipid composition and its preparing process
CN102716095A (en) * 2012-06-29 2012-10-10 海南灵康制药有限公司 Paclitaxel vesicle type phospholipid gel injection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张蓓: "紫杉醇脂质体及其冻干制剂的研究", 《中国优秀博硕士学位论文全文数据库(硕士) 医药卫生科技辑》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112789472A (en) * 2018-09-27 2021-05-11 玛阿特制药公司 Freeze-drying container
CN112789472B (en) * 2018-09-27 2023-02-17 玛阿特制药公司 Freeze-drying container

Also Published As

Publication number Publication date
CN106924195B (en) 2020-11-13

Similar Documents

Publication Publication Date Title
CN102133199B (en) Doxofylline lyophilized preparation for injection and preparation method thereof
CN103393632B (en) Cabazitaxel drug composition and preparation method thereof
CN106137969B (en) Docetaxel albumin nanoparticle pharmaceutical composition, preparation method and application thereof
CN107149592A (en) Biological self-assembly nano-crystalline injection and preparation method with lympha targeted function
CN102228430A (en) Nano-suspension for silybin-phospholipid complex and preparation method thereof
CN104721155B (en) A kind of temozolomide freeze-dried powder preparation and preparation method thereof
CN109078184B (en) Loaded double-drug nanoparticle and preparation method and application thereof
CN102406941A (en) Nanometer insoluble active component containing modified polyegline and preparation method thereof
CN103006586B (en) Epirubicin hydrochloride lyophilized injectable powder and preparation method thereof
CN104523606A (en) Method used for preparing gossypol and gossypol derivative pluronic nanoparticle via self-assembling
CN106924195A (en) A kind of lyophilized technique of injection Paclitaxel liposome composition
CN105078904B (en) A kind of Cabazitaxel lipid microspheres albumin freeze-dried powder and preparation method thereof
CN109820827B (en) Azacitidine freeze-dried powder injection for injection and preparation method thereof
CN104095816B (en) Lutein ester nano-particle and preparation method thereof
CN101890022B (en) Cefoperazone sodium and tazobactam sodium medicament composition liposome injection
CN108078931B (en) A kind of bendamustine hydrochloride freeze-dried powder needle and preparation method thereof
CN109044969B (en) Preparation method of paclitaxel injection
CN113925831A (en) High-stability phloretin nanosuspension, preparation method thereof and microneedle
CN113797171A (en) Pegylated recombinant human granulocyte colony stimulating factor freeze-dried preparation
CN102793678B (en) A kind of preparation method of the Docetaxel injection without tween
CN105748413B (en) Hydroxycamptothecin nano crystal load microballoon and preparation method thereof
CN104771374A (en) Preparation method of lactobionic acid azithromycin freeze-dried powder injection for injection and freeze-dried powder injection prepared by preparation method
Luo et al. Walnut peptide loaded proliposomes with hydroxyapatite as a carrier: Fabrication, environmental stability, and in vitro digestion attribute
CN113425689B (en) A nanometer preparation of Pithecellobium clypearia extract and its preparation method
CN114306275B (en) Pea peptide loaded soybean isoflavone composite nanoparticle and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant